TCHP Versus EC -THP as Neoadjuvant Treatment for HER2-Positive Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: HER2-Positive Breast Cancer
Interventions: DRUG: TCHP
Sponsor: Guangdong Provincial People's Hospital